New Treatment Options in Castration-Recurrent Prostate Cancer
This information was originally presented at the NCCN 20th Annual Conference: Advancing the Standard of Cancer Care™ held in Hollywood, Florida.
This activity is designed to meet the educational needs of oncologists, nurses, pharmacists, and other health care professionals who manage patients with cancer.
Following this activity, participants should be able to:
- Assess new strategies using novel and existing agents for metastatic prostate cancer
Andrew J. Armstrong, MD, ScM
Duke Cancer Institute
- 0.75 Participation
- 0.80 Nurse
- 0.75 Pharmacist
- 0.75 Physician